Research Paper Volume 15, Issue 21 pp 11891—11917
Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker
Figure 7. The scRNA-seq results of XCL2 expression and single-cell signature in pan-cancers. The definition of cancer cells in BRCA (A), CHOL (B), HNSC (C), KIRC (D), GBM (E), and PRAD (F). Enrichment analyses of interferon-alpha and interferon-gamma responses in BRCA (G), CHOL (H), HNSC (I), KIRC (J), GBM (K) and PRAD (L) single cell sequencing results.